Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VOXX
2426
DELISTED
VOXX International Corporation Class A
VOXX
| $1.36M | ﹤0.01% |
262,400
-3,200
| -1% | -$14.8K |
|
2427
Kewaunee Scientific
KEQU
$104M
| $1.36M | ﹤0.01% |
59,200
+200
| +0.3% | +$4.85K |
|
|
HSTO
2428
DELISTED
Histogen Inc. Common Stock
HSTO
| $1.36M | ﹤0.01% |
1,176
+257
| +28% | +$248K |
|
|
OTIV
2429
DELISTED
OTI On Track Innovations Ltd
OTIV
| $1.35M | ﹤0.01% |
819,300
+123,500
| +18% | +$207K |
|
2430
Ameresco
AMRC
$1.47B
| $1.35M | ﹤0.01% |
206,255
-24,333
| -11% | -$133K |
|
2431
Fate Therapeutics
FATE
$310M
| $1.34M | ﹤0.01% |
295,700
+85,800
| +41% | +$314K |
|
|
ATTU
2432
DELISTED
Attunity Ltd
ATTU
| $1.34M | ﹤0.01% |
169,700
+51,700
| +44% | +$383K |
|
|
SOL
2433
DELISTED
Emeren Group
SOL
| $1.33M | ﹤0.01% |
556,160
+53,200
| +11% | +$155K |
|
2434
Marcus & Millichap
MMI
$1.18B
| $1.33M | ﹤0.01% |
+54,200
| New | +$1.4M |
|
|
TTPH
2435
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $1.33M | ﹤0.01% |
7,234
-10,502
| -59% | -$1.18M |
|
2436
Southern First Bancshares
SFST
$612M
| $1.33M | ﹤0.01% |
40,619
+2,919
| +8% | +$99.7K |
|
|
SRLP
2437
DELISTED
SPRAGUE RESOURCES LP
SRLP
| $1.33M | ﹤0.01% |
48,927
+4,963
| +11% | +$135K |
|
|
TST
2438
DELISTED
TheStreet, Inc.
TST
| $1.32M | ﹤0.01% |
174,310
+2,470
| +1% | +$20K |
|
2439
Smart Sand
SND
$216M
| $1.32M | ﹤0.01% |
+81,100
| New | +$1.39M |
|
2440
Four Corners Property Trust
FCPT
$2.76B
| $1.3M | ﹤0.01% |
+57,000
| New | +$1.22M |
|
|
RC
2441
Ready Capital
RC
$292M
| $1.3M | ﹤0.01% |
89,800
-136,043
| -60% | -$1.85M |
|
2442
First US Bancshares
FUSB
$92.3M
| $1.29M | ﹤0.01% |
104,200
+32,100
| +45% | +$395K |
|
2443
CPI Card Group
PMTS
$333M
| $1.28M | ﹤0.01% |
61,160
+7,886
| +15% | +$179K |
|
|
VOLT
2444
DELISTED
Volt Information Sciences, Inc.
VOLT
| $1.28M | ﹤0.01% |
185,900
-400
| -0.2% | -$3K |
|
|
GPIC
2445
DELISTED
Gaming Partners International Corporation
GPIC
| $1.28M | ﹤0.01% |
128,100
+600
| +0.5% | +$6.67K |
|
|
TPH
2446
DELISTED
Tri Pointe Homes
TPH
| $1.28M | ﹤0.01% |
+101,736
| New | +$1.25M |
|
|
NEWS
2447
DELISTED
NewStar Financial, Inc.
NEWS
| $1.27M | ﹤0.01% |
120,400
-95,300
| -44% | -$925K |
|
|
SOHO
2448
DELISTED
Sotherly Hotels
SOHO
| $1.27M | ﹤0.01% |
198,900
+8,900
| +5% | +$61.4K |
|
|
WTT
2449
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.27M | ﹤0.01% |
857,100
+13,600
| +2% | +$22.8K |
|
|
AMED
2450
DELISTED
Amedisys
AMED
| $1.27M | ﹤0.01% |
24,800
-237,500
| -91% | -$11.3M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.